Products - Amgen
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have …
Amgen To Present 10 Abstracts From Its Dermatology Portfolio At …
Building upon the company's expertise in the science of using living cells to make biologic and biosimilar medicines, Amgen continues to expand its dermatology product portfolio, which …
Collaborating to Address Moderate to Severe Atopic Dermatitis
Jan 19, 2023 · That’s why Amgen, in collaboration with Kyowa Kirin, is pursuing research of rocatinlimab (AMG 451/KHK4083), a potential first-in-class, anti-OX40 monoclonal antibody …
FDA APPROVES OTEZLA® (APREMILAST) FOR THE TREATMENT …
THOUSAND OAKS, Calif., Dec. 20, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla ® …
Amgen To Showcase New Data From Inflammation Portfolio At …
THOUSAND OAKS, Calif., Sept. 13, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that new data from its expanding inflammation pipeline and marketed portfolio will …
FDA Accepts Amgen's Supplemental New Drug Application For …
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis Potential to Be First and Only Approved Oral Therapy …
Amgen and Kyowa Kirin to Jointly Develop and Commercialize …
Jun 1, 2021 · Amgen will consolidate sales for KHK4083 in all markets globally, except for Japan. Amgen also will leverage unique data from its deCODE Genetics subsidiary to inform the …
Senior Specialty Representative - Dermatology - Boston, MA
Dec 17, 2024 · We are actively searching for a Senior Specialty Representative to deliver on our commitment to serve patients. The Senior Specialty Representative acts as the primary …
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) …
Mar 10, 2024 · "Palmoplantar pustulosis can severely impact daily functioning due to its painful effects on the hands and feet, necessitating new therapeutic options for this impactful …
What We Do - Global Patient Safety | Amgen
Amgen collects, reviews, and evaluates adverse events, product complaints, and other safety findings experienced by patients, either as clinical trial participants who receive our …